Black Diamond Therapeutics, Inc. - Common Stock (BDTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
BDTX on Nasdaq
Shares outstanding
56,078,244
Price per share
$2.43
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
38,780,810
Total reported value
$146,973,938
% of total 13F portfolios
0%
Share change
+164,912
Value change
+$5,639,493
Number of holders
89
Price from insider filings
$2.43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Black Diamond Therapeutics, Inc. - Common Stock (BDTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BB BIOTECH AG 4.8% -69% $4,373,675 -$9,254,867 2,733,547 -68% BB Biotech AG 19 Mar 2025
BlackRock, Inc. 4.5% $4,037,634 2,523,521 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 89 institutional investors reported holding 38,780,810 shares of Black Diamond Therapeutics, Inc. - Common Stock (BDTX). This represents 69% of the company’s total 56,078,244 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Black Diamond Therapeutics, Inc. - Common Stock (BDTX) together control 65% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
T. Rowe Price Investment Management, Inc. 19% 10,744,107 +2.2% 0.02% $40,721,000
Vestal Point Capital, LP 9.9% 5,550,000 -0.89% 0.95% $21,034,500
NEA Management Company, LLC 7.9% 4,448,757 0% 0.93% $16,860,789
VANGUARD GROUP INC 3.9% 2,188,857 +4.1% 0% $8,295,768
TANG CAPITAL MANAGEMENT LLC 3.7% 2,070,209 0% 0.3% $7,846,092
MARSHALL WACE, LLP 2.3% 1,299,208 +76% 0.01% $4,923,996
Siren, L.L.C. 1.9% 1,046,517 0% 0.16% $3,966,299
BlackRock, Inc. 1.8% 1,028,092 -5.8% 0% $3,896,470
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.6% 896,853 +549% 0% $3,399,073
MILLENNIUM MANAGEMENT LLC 1.5% 850,331 -10% 0% $3,222,754
UBS Group AG 1.1% 628,416 +100% 0% $2,381,696
AWM Investment Company, Inc. 1.1% 600,000 +20% 0.21% $2,274,000
RENAISSANCE TECHNOLOGIES LLC 1.1% 599,400 +259% 0% $2,271,726
GEODE CAPITAL MANAGEMENT, LLC 0.89% 500,523 +1% 0% $1,897,600
NORTHERN TRUST CORP 0.87% 488,064 +222% 0% $1,849,763
ACADIAN ASSET MANAGEMENT LLC 0.86% 481,123 0% $1,820,000
DIMENSIONAL FUND ADVISORS LP 0.81% 455,870 0% 0% $1,727,463
FMR LLC 0.81% 453,558 +9.6% 0% $1,718,985
GOLDMAN SACHS GROUP INC 0.8% 449,018 +28% 0% $1,701,779
DAFNA Capital Management LLC 0.55% 307,070 -35% 0.29% $1,163,795
GLOBEFLEX CAPITAL L P 0.54% 305,276 0.18% $1,156,996
JANE STREET GROUP, LLC 0.42% 237,273 +14% 0% $899,265
STIFEL FINANCIAL CORP 0.4% 222,245 +1% 0% $842,310
XTX Topco Ltd 0.39% 216,195 +21% 0.04% $819,379
STATE STREET CORP 0.38% 213,513 0% 0% $809,214

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock (BDTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 50,914 $123,721 +$13,460 $2.43 3
2025 Q3 38,780,810 $146,973,938 +$5,639,493 $3.79 89
2025 Q2 38,616,493 $95,766,554 -$4,378,949 $2.48 92
2025 Q1 40,656,241 $63,017,852 -$11,756,469 $1.55 83
2024 Q4 47,903,925 $102,516,125 -$13,785,684 $2.14 85
2024 Q3 48,717,118 $211,892,256 +$1,570,817 $4.35 95
2024 Q2 46,760,739 $217,913,327 +$31,657,196 $4.66 88
2024 Q1 39,430,252 $199,910,697 +$10,671,909 $5.07 86
2023 Q4 38,119,952 $107,120,051 +$4,413,540 $2.81 73
2023 Q3 37,180,210 $106,709,201 -$21,943,325 $2.87 71
2023 Q2 41,421,828 $209,176,335 +$105,453,106 $5.05 72
2023 Q1 21,491,972 $40,617,428 +$846,555 $1.89 47
2022 Q4 21,053,167 $37,894,305 -$721,593 $1.80 56
2022 Q3 21,487,475 $36,340,473 -$284,945 $1.69 57
2022 Q2 21,498,645 $52,895,689 -$3,549,739 $2.46 56
2022 Q1 22,887,182 $64,088,307 -$2,429,770 $2.77 69
2021 Q4 23,198,177 $123,630,624 -$12,989,218 $5.33 83
2021 Q3 24,374,413 $206,301,397 -$11,175,534 $8.46 89
2021 Q2 25,397,669 $309,589,838 -$81,437,251 $12.19 97
2021 Q1 29,083,953 $705,520,847 -$7,557,586 $24.26 109
2020 Q4 28,616,097 $917,170,806 +$140,401,559 $32.05 109
2020 Q3 23,764,080 $718,480,421 +$753,590 $30.23 88
2020 Q2 22,835,597 $959,367,654 +$39,864,306 $42.16 79
2020 Q1 22,285,008 $555,219,061 +$555,219,061 $24.95 65